USD 0.17
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -182.18 Thousand USD | 17.93% |
2022 | -221.98 Thousand USD | 10.0% |
2021 | -246.64 Thousand USD | -60.89% |
2020 | -153.3 Thousand USD | 53.02% |
2019 | -326.33 Thousand USD | -462.6% |
2018 | -58 Thousand USD | 12.21% |
2017 | -66.07 Thousand USD | 86.42% |
2016 | -486.45 Thousand USD | -23922.42% |
2015 | -2025.00 USD | 0.0% |
2013 | -102.79 Thousand USD | -21.46% |
2012 | -84.63 Thousand USD | 0.0% |
2007 | -583.02 Thousand USD | 24.63% |
2006 | -773.53 Thousand USD | 21.38% |
2005 | -983.94 Thousand USD | -79.22% |
2004 | -549 Thousand USD | -2.13% |
2003 | -537.54 Thousand USD | 76.6% |
2002 | -2.29 Million USD | -299.9% |
2001 | -574.33 Thousand USD | 95.67% |
2000 | -13.27 Million USD | -842772.13% |
1999 | -1575.00 USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 73.72 Thousand USD | 316.87% |
2023 Q2 | -87.06 Thousand USD | -109.36% |
2023 Q4 | 17.68 Thousand USD | 124.83% |
2023 Q1 | -41.58 Thousand USD | -5.58% |
2023 FY | -182.18 Thousand USD | 17.93% |
2023 Q3 | -71.21 Thousand USD | 18.2% |
2022 Q2 | -51.92 Thousand USD | 21.32% |
2022 Q1 | -65.99 Thousand USD | 44.87% |
2022 Q4 | -39.39 Thousand USD | 39.09% |
2022 FY | -221.98 Thousand USD | 10.0% |
2022 Q3 | -64.67 Thousand USD | -24.54% |
2021 FY | -246.64 Thousand USD | -60.89% |
2021 Q3 | -68.75 Thousand USD | -104.13% |
2021 Q2 | -33.68 Thousand USD | -37.5% |
2021 Q4 | -119.7 Thousand USD | -74.11% |
2021 Q1 | -24.49 Thousand USD | 76.46% |
2020 Q1 | -27.58 Thousand USD | -27.47% |
2020 Q3 | -11.87 Thousand USD | -21.32% |
2020 Q4 | -104.05 Thousand USD | -776.32% |
2020 FY | -153.3 Thousand USD | 53.02% |
2020 Q2 | -9787.44 USD | 64.52% |
2019 FY | -326.33 Thousand USD | -462.6% |
2019 Q1 | -29.52 Thousand USD | -49.73% |
2019 Q2 | -18.48 Thousand USD | 37.39% |
2019 Q4 | -21.64 Thousand USD | -10.26% |
2019 Q3 | -19.62 Thousand USD | -6.15% |
2018 Q1 | -3959.71 USD | 0.0% |
2018 Q2 | -6970.20 USD | -76.03% |
2018 Q4 | -19.72 Thousand USD | 27.9% |
2018 Q3 | -27.35 Thousand USD | -292.41% |
2018 FY | -58 Thousand USD | 12.21% |
2017 FY | -66.07 Thousand USD | 86.42% |
2016 FY | -486.45 Thousand USD | -23922.42% |
2015 FY | -2025.00 USD | 0.0% |
2013 FY | -102.79 Thousand USD | -21.46% |
2012 FY | -84.63 Thousand USD | 0.0% |
2008 Q1 | -107.13 Thousand USD | 21.22% |
2008 Q3 | -107.92 Thousand USD | 11.83% |
2008 Q2 | -122.4 Thousand USD | -14.26% |
2007 Q3 | -145.79 Thousand USD | 1.87% |
2007 Q4 | -135.99 Thousand USD | 6.72% |
2007 FY | -583.02 Thousand USD | 24.63% |
2007 Q1 | -152.66 Thousand USD | 56.77% |
2007 Q2 | -148.57 Thousand USD | 2.68% |
2006 Q3 | -111.93 Thousand USD | 20.52% |
2006 FY | -773.53 Thousand USD | 21.38% |
2006 Q4 | -353.15 Thousand USD | -215.5% |
2006 Q2 | -140.82 Thousand USD | 13.92% |
2006 Q1 | -163.59 Thousand USD | -19.51% |
2005 Q4 | -136.89 Thousand USD | 36.2% |
2005 FY | -983.94 Thousand USD | -79.22% |
2005 Q3 | -214.57 Thousand USD | 55.64% |
2005 Q2 | -483.73 Thousand USD | -253.24% |
2005 Q1 | -136.94 Thousand USD | 8.62% |
2004 Q1 | -123.79 Thousand USD | 17.27% |
2004 FY | -549 Thousand USD | -2.13% |
2004 Q2 | -140.08 Thousand USD | -13.16% |
2004 Q3 | -117.82 Thousand USD | 15.89% |
2004 Q4 | -149.85 Thousand USD | -27.18% |
2003 Q4 | -149.63 Thousand USD | 7.49% |
2003 Q3 | -161.75 Thousand USD | -38.3% |
2003 Q2 | -116.96 Thousand USD | -12.94% |
2003 Q1 | -103.55 Thousand USD | 81.47% |
2003 FY | -537.54 Thousand USD | 76.6% |
2002 Q4 | -558.74 Thousand USD | -1038.72% |
2002 FY | -2.29 Million USD | -299.9% |
2002 Q3 | -49.06 Thousand USD | 96.3% |
2002 Q2 | -1.32 Million USD | 0.0% |
2001 FY | -574.33 Thousand USD | 95.67% |
2000 FY | -13.27 Million USD | -842772.13% |
1999 FY | -1575.00 USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Achiko AG | -9.32 Million USD | 98.046% |
Accelera Innovations, Inc | - USD | Infinity% |
Aspyra Inc. | -5.18 Million USD | 96.49% |
Cannabis Sativa, Inc. | -1.39 Million USD | 86.914% |
CompuMed, Inc. | -32.6 Thousand USD | -458.787% |
CompuGroup Medical SE & Co. KGaA | 45.91 Million USD | 100.397% |
Cogstate Limited | 5.44 Million USD | 103.343% |
CareView Communications, Inc. | -3.95 Million USD | 95.39% |
Craneware plc | 11.7 Million USD | 101.557% |
Caduceus Software Systems Corp. | -13.96 Million USD | 98.695% |
Certive Solutions Inc. | -1.67 Million USD | 89.091% |
Drug Free Solution, Inc. | -1.4 Million USD | 87.054% |
DATATRAK International, Inc. | 2.65 Million USD | 106.856% |
Healixa Inc. | -6.73 Million USD | 97.293% |
Easy Technologies Inc. | - USD | Infinity% |
eWellness Healthcare Corporation | - USD | Infinity% |
Founders Bay Holdings | 7.1 Million USD | 102.565% |
Health Discovery Corporation | - USD | Infinity% |
Healthcare Integrated Technologies, Inc. | -702.48 Thousand USD | 74.065% |
H-Source Holdings Ltd. | - USD | Infinity% |
InterCare DX, Inc. | -789.33 USD | -22981.221% |
IQ-AI Limited | -623.81 Thousand USD | 70.795% |
Cannabiz Mobile, Inc. | -750.00 USD | -24191.6% |
Mednow Inc. | -29.48 Million USD | 99.382% |
Galileo Life Sciences, Inc. | -248.24 Thousand USD | 26.609% |
MediXall Group, Inc. | -6.83 Million USD | 97.333% |
Mitesco, Inc. | -13.33 Million USD | 98.633% |
MobileSmith, Inc. | -14.12 Million USD | 98.71% |
NantHealth, Inc. | -67.77 Million USD | 99.731% |
Net Medical Xpress Solutions, Inc. | -1.85 Million USD | 90.189% |
OneLife Technologies Corp. | - USD | Infinity% |
ORHub, Inc. | -13.38 Million USD | 98.639% |
Patient Access Solutions, Inc. | -10.59 Million USD | 98.28% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | 113.905% |
PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 343.8% |
Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | -434.257% |
Renalytix Plc | -33.45 Million USD | 99.455% |
Revium Recovery Inc. | -683 Thousand USD | 73.325% |
RYAH Group, Inc. | - USD | Infinity% |
Carepay Inc. | 313.06 Thousand USD | 158.195% |
Vaso Corporation | 4.8 Million USD | 103.792% |
Vynleads, Inc. | -263.43 Thousand USD | 30.842% |